Dalifa Ramadhani

Ms. Dalifa Ramadhani

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
DRDalifa Ramadhani
Dalifa Ramadhani
RMRani Maharani
Rani Maharani
AGAmirah Mohd Gazzali
Amirah Mohd Gazzali
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi
Cyclic peptides have been widely reported to have therapeutic abilities in the treatment of cancer. This has been proven through in vitro and in vivo studies against breast, lung, liver, colon, and prostate cancers, among others. The multitude of data available in the literature supports the potential of cyclic peptides as anticancer agents. This review summarizes the findings from previously reported studies and discusses the different cyclic peptide compounds, the sources, and their modes of action as anticancer agents. The prospects and future of cyclic peptides will also be described to give an overview on the direction of cyclic peptide development for clinical applications.